MMP14
Matrix metalloproteinase-14
Also known as: MMP14_HUMAN, MT1-MMP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50281
- Gene
- MMP14
- Ensembl
- ENSG00000157227
- Chromosome
- 14
- Canonical length
- 582 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Intermediate filaments,Cytosol
OverviewNCBI Gene
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
582 residues, UniProt reviewed canonical sequence.
>P50281|MMP14
1 MSPAPRPPRC LLLPLLTLGT ALASLGSAQS SSFSPEAWLQ QYGYLPPGDL RTHTQRSPQS
61 LSAAIAAMQK FYGLQVTGKA DADTMKAMRR PRCGVPDKFG AEIKANVRRK RYAIQGLKWQ
121 HNEITFCIQN YTPKVGEYAT YEAIRKAFRV WESATPLRFR EVPYAYIREG HEKQADIMIF
181 FAEGFHGDST PFDGEGGFLA HAYFPGPNIG GDTHFDSAEP WTVRNEDLNG NDIFLVAVHE
241 LGHALGLEHS SDPSAIMAPF YQWMDTENFV LPDDDRRGIQ QLYGGESGFP TKMPPQPRTT
301 SRPSVPDKPK NPTYGPNICD GNFDTVAMLR GEMFVFKERW FWRVRNNQVM DGYPMPIGQF
361 WRGLPASINT AYERKDGKFV FFKGDKHWVF DEASLEPGYP KHIKELGRGL PTDKIDAALF
421 WMPNGKTYFF RGNKYYRFNE ELRAVDSEYP KNIKVWEGIP ESPRGSFMGS DEVFTYFYKG
481 NKYWKFNNQK LKVEPGYPKS ALRDWMGCPS GGRPDEGTEE ETEVIIIEVD EEGGGAVSAA
541 AVVLPVLLLL LVLAVGLAVF FFRRHGTPRR LLYCQRSLLD KVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MMP14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 149 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 149 nTPM
- adipose tissue: 143 nTPM
- cervix: 139 nTPM
- gallbladder: 139 nTPM
- blood vessel: 125 nTPM
- skin: 118 nTPM
Single-cell type
- extravillous trophoblasts: 375 nCPM
- decidual stromal cells: 198 nCPM
- syncytiotrophoblasts: 131 nCPM
- migrating cytotrophoblasts: 128 nCPM
- fibroblasts: 127 nCPM
- cytotrophoblasts: 122 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 126 nTPM
- thalamus: 26 nTPM
- medulla oblongata: 23 nTPM
- white matter: 19 nTPM
- midbrain: 15 nTPM
- pons: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MMP14.
Disease | AllUniProt
Conditions MMP14 is implicated in, by any mechanism.
- Winchester syndrome (WNCHRS) MIM:277950
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 381 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Winchester syndrome
ReferencesPubMed · IEDB
Publications for MMP14 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Five autoantibodies identified from immune complexes as breast cancer biomarkers.
2025 · Front Immunol · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.48
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- astrocyte cell migration
- branching morphogenesis of an epithelial tube
- cell motility
- cellular response to genistein
- chondrocyte proliferation
- collagen catabolic process
- craniofacial suture morphogenesis
- embryonic cranial skeleton morphogenesis
- endochondral ossification
- endodermal cell differentiation
- endothelial cell proliferation
- extracellular matrix disassembly
- extracellular matrix organization
- head development
- lung development
- male gonad development
- negative regulation of focal adhesion assembly
- negative regulation of Notch signaling pathway
- ovarian follicle development
- positive regulation of B cell differentiation
- positive regulation of cell growth
- positive regulation of cell migration
- positive regulation of macrophage migration
- positive regulation of myotube differentiation
- positive regulation of protein processing
- protein catabolic process
- protein processing
- proteolysis
- regulation of protein localization to plasma membrane
- response to estrogen
- response to hypoxia
- response to mechanical stimulus
- response to odorant
- response to oxidative stress
- skeletal system development
- tissue remodeling
- zymogen activation
- negative regulation of GDF15-GFRAL signaling pathway
Molecular functions
- endopeptidase activity
- integrin binding
- metalloaminopeptidase activity
- metalloendopeptidase activity
- serine-type endopeptidase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Hemopexin-like domain
- Peptidase M10, metallopeptidase
- Peptidoglycan binding-like
- Peptidase, metallopeptidase
- Hemopexin, conserved site
- Hemopexin-like repeats
- Peptidase M10A, cysteine switch, zinc binding site
- Peptidase M10A
- Peptidase M10A, matrix metallopeptidase, C-terminal
- Metallopeptidase, catalytic domain superfamily
- Peptidase M10A, catalytic domain
- PGBD-like superfamily
- Hemopexin-like domain superfamily
- Hemopexin
- Matrixin
- Putative peptidoglycan binding domain
- Domain of unknown function (DUF3377)
- PGBD superfamily
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MMP14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MMP14 as an antibody target. Whether an autoantibody or antibody against MMP14 could matter depends on whether native MMP14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MMP14 is annotated at the cell surface, where native MMP14 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MMP14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...